NEA Management Company, LLC - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 20 filers reported holding TREVI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$24,787,420
-8.8%
11,370,3760.0%1.91%
-7.7%
Q2 2023$27,175,199
+29.2%
11,370,3760.0%2.07%
+42.6%
Q1 2023$21,035,196
-4.2%
11,370,376
-0.0%
1.45%
+17.8%
Q4 2022$21,950,226
+25.3%
11,373,1740.0%1.23%
+41.2%
Q3 2022$17,515,000
-45.2%
11,373,1740.0%0.87%
-46.7%
Q2 2022$31,959,000
+86.4%
11,373,174
+406375.1%
1.64%
+231.5%
Q1 2022$17,144,000
+270.0%
2,798
-100.0%
0.50%
+426.6%
Q4 2021$4,634,000
-44.3%
5,940,7960.0%0.09%
-5.1%
Q3 2021$8,317,000
-37.8%
5,940,7960.0%0.10%
-43.1%
Q2 2021$13,367,000
-17.0%
5,940,7960.0%0.17%
-51.8%
Q1 2021$16,100,000
+12.0%
5,940,7960.0%0.36%
-5.0%
Q4 2020$14,377,000
-39.9%
5,940,7960.0%0.38%
-62.5%
Q3 2020$23,941,000
-38.8%
5,940,7960.0%1.01%
-35.5%
Q2 2020$39,090,000
+167.5%
5,940,796
+33.8%
1.57%
+105.9%
Q1 2020$14,612,000
-12.3%
4,441,3600.0%0.76%
-3.2%
Q4 2019$16,655,000
-16.7%
4,441,3600.0%0.79%
-52.4%
Q3 2019$19,986,000
-39.8%
4,441,360
+0.3%
1.66%
-28.9%
Q2 2019$33,224,0004,429,8042.33%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 11,370,376$24,787,4201.91%
Fairmount Funds Management LLC 5,163,287$11,255,9661.35%
Opaleye Management Inc. 1,705,900$3,718,8621.21%
Frazier Life Sciences Management, L.P. 6,881,090$15,000,7761.00%
VR Adviser, LLC 3,422,397$7,460,8250.78%
SILVERARC CAPITAL MANAGEMENT, LLC 927,415$2,021,7650.61%
Rubric Capital Management LP 5,684,420$12,392,0360.46%
Tejara Capital Ltd 180,227$392,8950.22%
PFS Partners, LLC 100,000$218,0000.19%
WealthTrust Axiom LLC 93,500$203,8300.07%
View complete list of TREVI THERAPEUTICS INC shareholders